We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna. We run an interrupted time series analysis on monthly data for the three market-leading statins, focusing on economic shocks due to generic entries of simvastatin (April 2007) and atorvastatin (March 2012). We find significant variations in long-term trends and abrupt jumps in volumes and number of patients, involving the molecule losing patent protection and its competitors within the same family. Through counterfactual analysis, we provide comprehensive estimates of the cost savings associated with generication and show that the effect due to spillovers across molecules can be relatively large. Finally, we find evidence of heterogeneous effects across age groups and between naïve patients and the rest of the population. On the whole, prescribers’ behaviour comes out as sensitive to price changes even in an NHS context where patients and physicians are mostly shielded from the financial consequences of choosing a specific molecule. Our evidence is consistent with the view that, when generication increases the price gap across alternative compounds, physicians adjust prescriptions to changes in the cost-effectiveness ratio and align their choice with policymakers’ objectives more closely.

The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour / Fiorentini, Gianluca; Bruni, Matteo Lippi; Mammi, Irene. - In: JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION. - ISSN 0167-2681. - STAMPA. - 204:(2022), pp. 37-68. [10.1016/j.jebo.2022.10.003]

The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour

Fiorentini, Gianluca;Bruni, Matteo Lippi
;
2022

Abstract

We study the evolution of statin consumption between 2005-2017 in the Italian region Emilia-Romagna. We run an interrupted time series analysis on monthly data for the three market-leading statins, focusing on economic shocks due to generic entries of simvastatin (April 2007) and atorvastatin (March 2012). We find significant variations in long-term trends and abrupt jumps in volumes and number of patients, involving the molecule losing patent protection and its competitors within the same family. Through counterfactual analysis, we provide comprehensive estimates of the cost savings associated with generication and show that the effect due to spillovers across molecules can be relatively large. Finally, we find evidence of heterogeneous effects across age groups and between naïve patients and the rest of the population. On the whole, prescribers’ behaviour comes out as sensitive to price changes even in an NHS context where patients and physicians are mostly shielded from the financial consequences of choosing a specific molecule. Our evidence is consistent with the view that, when generication increases the price gap across alternative compounds, physicians adjust prescriptions to changes in the cost-effectiveness ratio and align their choice with policymakers’ objectives more closely.
2022
The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour / Fiorentini, Gianluca; Bruni, Matteo Lippi; Mammi, Irene. - In: JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION. - ISSN 0167-2681. - STAMPA. - 204:(2022), pp. 37-68. [10.1016/j.jebo.2022.10.003]
Fiorentini, Gianluca; Bruni, Matteo Lippi; Mammi, Irene
File in questo prodotto:
File Dimensione Formato  
The_same_old_medicine.pdf

embargo fino al 18/10/2025

Tipo: Postprint
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 4.38 MB
Formato Adobe PDF
4.38 MB Adobe PDF   Visualizza/Apri   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/896743
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact